Innovation on Demand Part 1: Implementing Culturally-Responsive and Trauma-Informed Telehealth Services and Family-Centered Practice During COVID-19

Innovation on Demand Part 1: Implementing Culturally-Responsive and Trauma-Informed Telehealth Services and Family-Centered Practice During COVID-19

Monday, May 4, 2020, 3:00pm – 4:30pm EST (12:00 p.m. – 1:30 p.m. PST) 

This virtual dialogue is part of a three-part series. To learn more about the rest of the series, please click for Part 2 and Part 3. To download our event flyer (PDF), please visit: https://wp.me/a8nsIW-6eT

Please click here to view the recording (Zoom link)

Please click here to download the closed-captioning transcript (Word) 

 

Child Witness to Violence Project Materials: click here to download Telehealth Tip Sheet (PDF), click here to download Informed Consent to Telehealth Counseling Form (PDF)

House of Ruth Materials:

Description: 

In Part 1, presenters will share how they offer virtual services with families impacted by domestic violence during the COVID-19 pandemic. Panelists will discuss equity and safety issues with telehealth counseling. They will share what it takes to create safer virtual environments with children and adult survivors of domestic violence and abusive partners.

This dialogue will be recorded and closed-captioned. The slides, recording and closed-captioning transcript will be posted here. 

 

Presenters:

 

Questions? Accessibility Needs? Please contact Jess Fournier at jfournier@futureswithoutviolence.org 

 

Logos for Promising Futures & Quality Improvement Center on Domestic Violence in Child Welfare projects

These webinars are funded through the Department of Health and Human Services, Administration for Children and Families, Children’s Bureau, Grant #90CA1850-01, and Grant Number 90EV0434-01-00 from the Administration on Children, Youth and Families, Family and Youth Services Bureau, U.S. Department of Health and Human Services. The content of these webinars does not necessarily reflect the view or policies of the funder, nor does mention of trade names, commercial products or organizations imply endorsement by the US Department of Health and Human Services.